{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-028495","form_type":"8-K","ticker":"MCK","cik":"0000927653","company_name":"MCKESSON CORP","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.859236+00:00","generated_at":"2026-05-20T05:19:42.713008+00:00","sec_items":["2.03","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"McKesson issues $2B notes to fund acquisition of 70% stake in Community Oncology Revitalization","bullets":["Issued $650M 4.650% notes due 2030, $650M 4.950% notes due 2032, $700M 5.250% notes due 2035.","Net proceeds ~$1.99B; combined with cash on hand to fund acquisition of 70% controlling interest in Community Oncology Revitalization Enterprise Ventures (Florida Cancer Specialists).","Interest payable semi-annually on May 30 and Nov 30, starting Nov 30, 2025.","Notes are unsecured, unsubordinated, rank equally with existing unsecured debt; change of control/rating downgrade triggers repurchase offer at 101% plus accrued interest.","Underwriters include Barclays, BofA Securities, Deutsche Bank, J.P. Morgan."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-028495","json":"https://secwatch.observer/filing/0001628280-25-028495.json","markdown":"https://secwatch.observer/filing/0001628280-25-028495.md","text":"https://secwatch.observer/filing/0001628280-25-028495.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/927653/000162828025028495/0001628280-25-028495-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/927653/000162828025028495/mck-20250520.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T05:19:42.713008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1dc65cb15148c5233d61536c39dfaaa649d9fa8c","claim":"MCKESSON CORP incurred senior notes of $650,000,000 in aggregate principal amount of the Company's 4.650% Notes due 2030 at 4.650% maturing 2030.","evidence_excerpt":"$650,000,000 in aggregate principal amount of the Company's 4.650% Notes due 2030 (the \"2030 Notes\"), $650,000,000 in aggregate principal amount of the Company's 4.950% Notes due 2032 (the \"2032 Notes\") and $700,000,000 in aggregate principal amount of the Company's 5.250% Notes due 2035 (the \"2035 Notes\" and, together with the 2030 Notes and 2032 Notes, the \"Notes\")","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/927653/000162828025028495/0001628280-25-028495-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"senior notes"},{"label":"Principal","value":"$650,000,000 in aggregate principal amount of the Company's 4.650% Notes due 2030"},{"label":"Rate","value":"4.650%"},{"label":"Maturity","value":"2030"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}